ArticleThe Lancet regional health. Europe2023

Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.

Bang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.